Ease Labs was founded in 2018 with the objective of developing innovative natural solutions that improve people's health and well-being.

The group is composed of Ease Labs Pharma, Semeya and Ease Labs Colômbiacombining expertise in the production, research, and development of Cannabis-derived products and other botanical active ingredients from the Brazilian biodiversity.

With a fully integrated approach, Ease Labs controls all stages of the production process, from plant cultivation to final product delivery.

At the Ease Labs Pharma facilities, in addition to the production plant, we have a laboratory for physical-chemical and microbiological analyses and our Research and Development (R&D) laboratory. All processes undergo rigorous control, ensuring the quality and safety of our products.

Our manufacturing structure has the Good Manufacturing Practices Certification (CBPF),
demonstrating our commitment to the highest standards of quality and safety established by Anvisa.

Ease Labs is a pioneer in the Brazilian pharmaceutical sector specialized in cannabis-based products.
It stands out for its integrated approach, controlling all stages of the production process, from the cultivation of the plants to the delivery of the final product.

Committed to the development of cannabis-derived products, Ease Labs reaffirms its position at the forefront of the industry. Its activities go beyond production, including participation in scientific research and partnerships with renowned institutions such as Anvisa and CERTBIO, actively contributing to advances in the therapeutic use of cannabis.

Choosing Ease Labs means trusting a brand that combines science, responsibility, and pioneering spirit to offer solutions that truly make a difference in people's lives.

With production based in Brazil Ease Labs serves the market with agility, offering high-quality products in compliance with Anvisa’s regulatory standards and at accessible prices. We are present throughout the country, ensuring wide access to safe and quality treatments for patients and doctors.

We are a reference in the research and development of cannabis-based products.

Our teams collaborate with renowned universities and research centers such as USP and UFMG. We are developing clinical trials to demonstrate the efficacy and safety of our formulations. Treatments with cannabinoids have shown promising results.